Menu
Recruiting NCT07228806

Effectiveness of Telerehabilitation on Pelvic Floor Dysfunction at Postpartum Woman

No phase Interventional Postpartum Pelvic Floor Function and Symptoms

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Pelvic floor exercises with telerehabilitation, Pelvic floor exercises without telerehabilitation.
Who it may be relevant to
Registry conditions: Postpartum Pelvic Floor Function and Symptoms. Basic parameters: 18 years — 45 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Turkey (Türkiye)
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Evaluation of the Effectiveness of Telerehabilitation on Pelvic Floor Dysfunction in Postpartum Women: A Single-Blind Randomised Controlled Trial

Overview

These events are largely due to pelvic floor dysfunction that develops after pregnancy. Kegel exercises and core stabilisation exercises performed in the postpartum period are important in preventing pelvic floor dysfunction. However, considering the mother's adaptation process to both the baby and her new life in the postpartum period, there may be problems with exercise compliance. Increasing exercise compliance through telerehabilitation can be effective in preventing pelvic floor dysfunction and improving women's quality of life.

Interventions

  • Other Pelvic floor exercises with telerehabilitation
    Patients in the telerehabilitation group will be assigned the same 8-week exercise programme as those in the conventional group to be carried out at home. Unlike the conventional group, patients in the telerehabilitation group will be contacted by telephone each week throughout the exercise programme to check their adherence to the programme, to ask if they have encountered any problems with the exercise programme, and to answer any questions they may have.
  • Other Pelvic floor exercises without telerehabilitation
    An 8-week exercise programme consisting of 45-minute Kegel exercises and core stabilisation exercises per day will be provided for implementation at home in the conventional group.

Primary outcome measures

  • Pelvic floor muscle strength assessment [Time frame: Before exercises programme and 8th week of exercises programme]
Secondary outcome measures (3)
  • Measurement of the distance between the inferior edge of the pubic symphysis and the anteromedial edge of the puborectalis muscle using transperineal ultrasound [Time frame: Before exercises programme and 8th week of exercises programme]
  • Pelvic floor questionnaire for pregnant and postpartum women [Time frame: Before exercises programme and 8th week of exercises programme]
  • Female Sexual Function Index [Time frame: Before exercises programme and 8th week of exercises programme]

Eligibility criteria

Inclusion criteria

  • Aged between 18 and 45
  • Primiparous women
  • Term vaginal delivery
  • 6 weeks postpartum
  • Willingness to participate in the study

Exclusion criteria

  • Presence of faecal or urinary incontinence prior to pregnancy
  • Use of assisted delivery devices (vacuum, forceps)
  • Presence of neurological disease
  • Presence of psychiatric illness or cognitive problems that make it difficult to answer questions
  • Caesarean section delivery
  • History of diabetes mellitus
  • Perineal rupture

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Prevention

Study locations

Turkey (Türkiye) · 1 center
  • Ankara Etlik City Hospital — Ankara

Identifiers

NCT: NCT07228806 · AEŞH-EK-2025-062

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗